Want to join the conversation?
$VOXX said the company expects FY17 to show organic growth on a dollar to dollar basis, with significant improvements in operating income, net income and adjusted EBITDA. $VOXX also expects to generate positive cash flow, while reducing debt in FY17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.